Industry NewsNHS study confirms OGT’s CytoSure Constitutional v3 array has significantly higher reporting rate for developmental disorder research
Product NewsNew Whitepaper from Oxford Gene Technology Highlights the Impact of NGS Target Enrichment Assay Choice
Product NewsOGT Launches Pre-implantation Genetic Screening Array Aimed at Improving the Chances of Successful IVF
Product NewsOGT Launches New Solid Tumour Profiling Service to Predict Patient Response to Cancer Treatment
Product NewsOGT Granted Licence by The Institute of Cancer Research, London, to Develop and Commercialize Prostate Cancer Biomarker Panel
